Treatment for the Mental Health Impact of Killing in War
1 other identifier
observational
8
1 country
1
Brief Summary
The goal of this project is to test the feasibility, acceptability, and efficacy of a treatment module addressing the mental health and functional impact of killing in the war zone. The investigators will enroll between 12-20 Veterans who have killed in war and have been diagnosed with post-traumatic stress disorder (PTSD) for a pilot study assessing the efficacy of the six-session treatment. Veterans will be randomized either to the treatment or to the waitlist control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2011
CompletedFirst Posted
Study publicly available on registry
August 1, 2011
CompletedStudy Start
First participant enrolled
October 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedAugust 18, 2014
August 1, 2014
1.7 years
July 19, 2011
August 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in psychological symptoms as measured by the Symptom Checklist-90 (SCL-90-R)
A brief multidimensional self-report inventory that screens for nine symptoms of psychopathology and provides three global distress indicators.
Measured at baseline and study completion (week 7)
Secondary Outcomes (1)
Change in killing-related maladaptive cognitions as measured by the Killing Cognitions Scale (KCS)
Measured at baseline and study completion (week 7)
Interventions
Treatment will include six, one hours sessions with a licensed clinical psychologist or an advanced postdoctoral fellow under the close supervision of a licensed psychologist.
Eligibility Criteria
Combat veterans
You may qualify if:
- Diagnosis of PTSD
- Veteran will need to endorse having taken another life in a war zone context
- Have received some prior evidence-based treatment for PTSD
You may not qualify if:
- Meet current or lifetime criteria for a psychotic disorder
- Participants in current PTSD treatment will not be excluded;however,if receiving medications they will need to be stabilized on current medications for at least one month.
- If receiving Prolonged Exposure Therapy or Cognitive Behavioral Therapy, individuals will need to wait two weeks after they have completed the treatment to enroll in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
San Francisco VA Medical Center
San Francisco, California, 94121, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shira Maguen, PhD
University of California San Francisco/ San Francisco VA Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2011
First Posted
August 1, 2011
Study Start
October 1, 2011
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
August 18, 2014
Record last verified: 2014-08